A Lattuada
Overview
Explore the profile of A Lattuada including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
79
Citations
308
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Pappalardo F, Della Valle P, Maj G, Franco A, Lattuada A, Landoni G, et al.
HSR Proc Intensive Care Cardiovasc Anesth
. 2013 Feb;
2(2):119-27.
PMID: 23440905
Introduction: No data exist on the prevalence of primary hemostatic defects and acquired von Willebrand disease in mitral valve prolapse with severe regurgitation. Methods: Primary hemostasis was evaluated by PFA-100,...
2.
Mannucci P, Canciani M, Forza I, Lussana F, Lattuada A, Rossi E
Blood
. 2001 Oct;
98(9):2730-5.
PMID: 11675345
Congenital or immunomediated deficiencies of the metalloprotease that cleaves physiologically von Willebrand factor (vWF) reduce or abolish the degradation of ultralarge vWF multimers that cause the formation of intravascular platelet...
3.
Castaman G, Eikenboom J, Lattuada A, Rodeghiero F
Thromb Haemost
. 2000 Nov;
84(4):729-30.
PMID: 11057881
No abstract available.
4.
Pareti F, Lattuada A, Bressi C, Zanobini M, Sala A, Steffan A, et al.
Circulation
. 2000 Sep;
102(11):1290-5.
PMID: 10982545
Background: Excessive bleeding may complicate congenital cardiac defects. To explain the pathogenesis of this abnormality, we evaluated selected parameters of primary hemostasis in patients with aortic valve stenosis before and...
5.
Castaman G, Eikenboom J, Lattuada A, Mannucci P, Rodeghiero F
Br J Haematol
. 2000 Jan;
108(1):188-90.
PMID: 10651743
We studied the proteolytic pattern of the mutant von Willebrand factor (VWF) in four patients with von Willebrand disease (VWD) who were either homozygous or hemizygous for the mutation C2362F....
6.
Ferro D, Basili S, Lattuada A, Mantovani B, Bellomo A, Mannucci P, et al.
Ital J Gastroenterol Hepatol
. 1998 Mar;
29(5):434-40.
PMID: 9494853
Background: The pathophysiologic mechanism underlying the association between endotoxaemia and clotting activation in liver cirrhosis is still to be explained. Aims: To investigate the relationship between endotoxaemia, endothelial perturbation and...
7.
Lattuada A, Mannucci P, Chen C, Legnani C, Palareti G
Thromb Haemost
. 1997 Aug;
78(2):813-9.
PMID: 9268177
During orthotopic liver transplantation (OLT) excessive bleeding is the main cause of death and graft failure. The acute bleeding tendency that accompanies OLT, particularly during the anhepatic period and after...
8.
Ferro D, Quintarelli C, Lattuada A, Leo R, Alessandroni M, Mannucci P, et al.
Hepatology
. 1996 Jun;
23(6):1377-83.
PMID: 8675154
The aim of this study was to evaluate whether there is endothelial dysfunction in patients with cirrhosis and to detect the mechanism that may account for it. We measured plasma...
9.
Englender T, Lattuada A, Mannucci P, Sadler J, Inbal A
Blood
. 1996 Apr;
87(7):2788-94.
PMID: 8639896
Type 2A von Willebrand disease (vWD), the most common qualitative form of vWD, is characterized by a relative decrease in circulating intermediate and high molecular weight (HMW) multimers. We studied...
10.
Federici A, Falanga A, Lattuada A, DI Rocco N, Barbui T, Mannucci P
Br J Haematol
. 1996 Mar;
92(3):733-9.
PMID: 8616045
Plasma von Willebrand factor (VWF) was investigated in five patients with acute promyelocytic leukaemia (APL) before and after administration of the differentiating agent all-trans-retinoic acid (ATRA). The purpose of this...